ARCHIVES

BCDDP “Major Accomplishment” Described By ACS’ Holleb

This article is from The Cancer Letter archive.

Vol. 04 No. 29 | July 21, 1978

Download PDF Visit The Full Archive

Related Articles

House Passes Bill Authorizing NIH Funds; Veto Likely

August 2, 1991

ODAC To Review Taxol Nov. 16; NCI, Bristol to Discuss Pricing

October 23, 1992

Arzerra Maintenance Therapy Extends PFS In Phase III Trial, Compared to Observation

August 29, 2014

Cytyc Buys Pro-Duct Health, Ductal Lavage Device Maker. TAP To Pay $875 Million To Settle Federal Civil Suit.

October 26, 2001

Stronger Federal Role Needed To Improve Palliative Care.

June 22, 2001

In Brief: NCI Will Stop Free Group C distribution Of VP-16 Sept. 1 Unless Bristol Supplies It At No Charge

June 25, 1982